Supplementary protection
LT - Dioksa-biciklo[3.2.1.]oktan-2,3,4-triolio dariniai
EN - DIOXA-BICYCLO[3.2.1.]OCTANE-2,3,4-TRIOL DERIVATIVES
SPC
| (11) |
Number of the document |
C 2334687 |
| (68) |
Number of the document |
2334687
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2018 510 |
| (22) |
Date of filing the application |
2018-08-21 |
| (41) |
Date of publication of the application |
2018-09-25 |
|
Date of publication of SPC |
2019-09-10 |
| (24) |
Date of coming into effect of SPC |
2029-08-18 |
Applicant
| (71) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
Grantee
| (73) |
Pfizer Inc.,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/18/1267, 2018-03-21
|
Calculated date of expiry of the SPC
| (94) |
2033-03-23 |
Name of the product protected by the basic patent
| (95) |
Ertugliflozinas, pasirinktinai kaip kristalinė forma, ypač kaip ko-kristalas su L-piroglutamo rūgštimi, ir ypač kaip ertugliflozino L-piroglutamo rūgštis |
